Curcumin attenuates autoimmunity and renal injury in an experimental model of systemic lupus erythematosus-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Curcumin attenuates autoimmunity and renal injury in an experimental model of systemic lupus erythematosus

Published:2020-07 Issue:13 Volume:8 Page:
ISSN:2051-817X
Container-title:Physiological Reports
language:en
Short-container-title:Physiol Rep

Author:

Dent Elena L.¹,Taylor Erin B.¹,Turbeville Hannah R.²,Ryan Michael J.¹³

Affiliation:

1. Department of Physiology & Biophysics University of Mississippi Medical Center Jackson MS USA

2. Department of Pharmacology and Toxicology University of Mississippi Medical Center Jackson Mississippi USA

3. GV (Sonny) Montgomery Veterans Affairs Medical Center Jackson Mississippi USA

Funder

National Institutes of Health

American Heart Association

Publisher

Wiley

Subject

Physiology (medical),Physiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.14814/phy2.14501

Reference72 articles.

1. CURCUMIN: THE INDIAN SOLID GOLD

2. Mechanics insights of curcumin in myocardial ischemia: Where are we standing?

3. Cardiovascular risk factor screening in systemic lupus erythematosus;Al‐Herz A.;Journal of Rheumatology,2003

4. Kidney disease in lupus is not always 'lupus nephritis'

5. Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacological Mechanism of Chinese Medicine in Systemic Lupus Erythematosus: A Narrative Review;Chinese Journal of Integrative Medicine;2024-09-05

2. The effects of lifestyle interventions on disease activity and quality of life in patients with systemic lupus erythematosus: A systematic review;Autoimmunity Reviews;2024-08

3. Curcumin as a pharmaceutical leader;Curcumin-Based Nanomedicines as Cancer Therapeutics;2024

4. A Review of the Potential Benefits of Herbal Medicines, Small Molecules of Natural Sources, and Supplements for Health Promotion in Lupus Conditions;Life;2023-07-19

5. Advances in natural products and antibody drugs for SLE: new therapeutic ideas;Frontiers in Pharmacology;2023-07-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3